Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Iversen

Showing results (101-110 of 156) with videos related to

Pageof 16
Sort By:
BJU International|January 30, 2016
The impact of the 2005 International Society of Urological Pathology consensus guidelines on Gleason grading - a matched-pair analysisKasper D Berg, Frederik B Thomsen, Camilla Nerstrøm, et al.
Neuropharmacology|January 11, 2015
Decreased in vivo α2 adrenoceptor binding in the Flinders Sensitive Line rat model of depressionAnne M Landau, Jenny-Ann Phan, Peter Iversen, et al.
European Urology|March 18, 2014
ERG protein expression in diagnostic specimens is associated with increased risk of progression during active surveillance for prostate cancerKasper Drimer Berg, Ben Vainer, Frederik Birkebæk Thomsen, et al.
Biomarkers in Medicine|January 15, 2016
Copenhagen uPAR prostate cancer (CuPCa) database: protocol and early resultsSolvej Lippert, Kasper D Berg, Gunilla Høyer-Hansen, et al.
EJNMMI Research|September 6, 2021
A novel read methodology to evaluate the optimal dose of <sup>68</sup>Ga-satoreotide trizoxetan as a PET imaging agent in patients with gastroenteropancreatic neuroendocrine tumours: a phase II clinical trialColin G Miller, Henning Grønbæk, Irene Virgolini, et al.
Journal of Clinical Pathology|June 11, 2015
ERG protein expression over time: from diagnostic biopsies to radical prostatectomy specimens in clinically localised prostate cancerKasper Drimer Berg, Klaus Brasso, Frederik Birkebæk Thomsen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 8, 2019
Finasteride Use and Risk of Male Breast Cancer: A Case-Control Study Using Individual-Level Registry Data from Denmark, Finland, and SwedenThora M Kjærulff, Annette K Ersbøll, Anders Green, et al.
Pharmacoepidemiology and Drug Safety|February 13, 2020
Characteristics of finasteride users in comparison with nonusers: A Nordic nationwide study based on individual-level data from Denmark, Finland, and SwedenThora Majlund Kjaerulff, Annette Kjaer Ersbøll, Eero Pukkala, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 31, 2016
Heart failure patients with prediabetes and newly diagnosed diabetes display abnormalities in myocardial metabolismRoni Nielsen, Anders Jorsal, Peter Iversen, et al.
International Journal of Cancer|October 30, 2004
Expression of urokinase plasminogen activator, its receptor and type-1 inhibitor in malignant and benign prostate tissuePernille Autzen Usher, Ole Frøkjaer Thomsen, Peter Iversen, et al.
Pageof 16

Showing results (101-110 of 156) with videos related to

Sort By:
Pageof 16
BJU International|January 30, 2016
The impact of the 2005 International Society of Urological Pathology consensus guidelines on Gleason grading - a matched-pair analysisKasper D Berg, Frederik B Thomsen, Camilla Nerstrøm, et al.
Neuropharmacology|January 11, 2015
Decreased in vivo α2 adrenoceptor binding in the Flinders Sensitive Line rat model of depressionAnne M Landau, Jenny-Ann Phan, Peter Iversen, et al.
European Urology|March 18, 2014
ERG protein expression in diagnostic specimens is associated with increased risk of progression during active surveillance for prostate cancerKasper Drimer Berg, Ben Vainer, Frederik Birkebæk Thomsen, et al.
Biomarkers in Medicine|January 15, 2016
Copenhagen uPAR prostate cancer (CuPCa) database: protocol and early resultsSolvej Lippert, Kasper D Berg, Gunilla Høyer-Hansen, et al.
EJNMMI Research|September 6, 2021
A novel read methodology to evaluate the optimal dose of <sup>68</sup>Ga-satoreotide trizoxetan as a PET imaging agent in patients with gastroenteropancreatic neuroendocrine tumours: a phase II clinical trialColin G Miller, Henning Grønbæk, Irene Virgolini, et al.
Journal of Clinical Pathology|June 11, 2015
ERG protein expression over time: from diagnostic biopsies to radical prostatectomy specimens in clinically localised prostate cancerKasper Drimer Berg, Klaus Brasso, Frederik Birkebæk Thomsen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 8, 2019
Finasteride Use and Risk of Male Breast Cancer: A Case-Control Study Using Individual-Level Registry Data from Denmark, Finland, and SwedenThora M Kjærulff, Annette K Ersbøll, Anders Green, et al.
Pharmacoepidemiology and Drug Safety|February 13, 2020
Characteristics of finasteride users in comparison with nonusers: A Nordic nationwide study based on individual-level data from Denmark, Finland, and SwedenThora Majlund Kjaerulff, Annette Kjaer Ersbøll, Eero Pukkala, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 31, 2016
Heart failure patients with prediabetes and newly diagnosed diabetes display abnormalities in myocardial metabolismRoni Nielsen, Anders Jorsal, Peter Iversen, et al.
International Journal of Cancer|October 30, 2004
Expression of urokinase plasminogen activator, its receptor and type-1 inhibitor in malignant and benign prostate tissuePernille Autzen Usher, Ole Frøkjaer Thomsen, Peter Iversen, et al.
Pageof 16